Tokyo, Japan

Mihoko Ohtaka

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1982.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mihoko Ohtaka: Innovator in Anti-Tumor Preparations

Introduction

Mihoko Ohtaka is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical science, particularly in the development of anti-tumor preparations. Her innovative work has the potential to impact cancer treatment positively.

Latest Patents

Mihoko Ohtaka holds a patent for an anti-tumor preparation against certain tumors. This preparation contains cells of Streptococcus equisimilis and involves a unique process for preparing the preparation. The process includes subjecting the cells to heat treatment in a salt solution, with or without penicillin treatment. This patent showcases her dedication to advancing medical treatments.

Career Highlights

Ohtaka is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at this company has allowed her to focus on innovative research and development in the field of oncology. Her contributions have been recognized within the industry, highlighting her expertise and commitment to improving patient outcomes.

Collaborations

Mihoko Ohtaka has collaborated with notable colleagues, including Yasuhisa Takeda and Takashi Matsuno. These collaborations have fostered a productive environment for research and innovation, leading to advancements in cancer treatment.

Conclusion

Mihoko Ohtaka's work in developing anti-tumor preparations exemplifies her commitment to medical innovation. Her contributions are paving the way for new treatment options in oncology, showcasing the importance of research and collaboration in the fight against cancer.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…